Hepatic hemangiomas, most of which are cavernous hemangiomas, are common benign tumors of the liver that can occur at any age, but often present in adults and are more common in women. Hepatic hemangioma is the most common benign tumor in the liver. Most cases are diagnosed preoperatively and most are asymptomatic, with a few presenting with discomfort in the liver due to the size of the tumor. If the tumor tends to increase in size or is located under the liver envelope, there is a possibility of hemorrhage and life-threatening, and should be treated as early as possible. Compared with surgery, interventional treatment of hepatic hemangioma is relatively safe, non-invasive, with minimal damage, good results, and quick recovery, and generally no postoperative complications. The patient can be discharged from the hospital shortly after treatment. It offers a new option for patients with hepatic hemangioma and can ensure a good quality of life. Typical case: On December 5, 2013, our oncology department successfully performed super-selective hepatic artery embolization under DSA for a patient with a giant hepatic hemangioma. The patient, a 41-year-old male, had been found to have a hepatic hemangioma for more than 3 years and presented to the hospital with recent enlargement of the tumor and discomfort in the liver area. Due to the large size of the tumor and the high risk of bleeding from surgical resection, he was treated with hepatic artery embolization. He was discharged from the hospital with significant relief of symptoms after treatment.